PPD02.03 Tepotinib in Patients with MET Exon 14 (METex14) Skipping NSCLC: Analysis of All Patients From VISION Cohorts A and C
Year: 2023
Type: conference-abstract
Source: Journal of Thoracic Oncology
Institutions: University of Chicago, Fondazione IRCCS Istituto Nazionale dei Tumori, Heidelberg University, German Center for Lung Research, Vall d'Hebron Institute of Oncology, Ageo Central General Hospital, The University of Texas MD Anderson Cancer Center, Centre Hospitalier Universitaire de Bordeaux, The Netherlands Cancer Institute, Université Toulouse III - Paul Sabatier, Centre Hospitalier Universitaire de Toulouse, Centre National de la Recherche Scientifique, Inserm, Université de Lille, Institut Pasteur de Lille, Centre Hospitalier Universitaire de Lille, Centre de Recherches en Cancérologie de Lille, Antwerp University Hospital, Instituto Oncológico Dr. Rosell, Hospital Universitario Dexeus, IDCQ Hospitales y Sanidad, S.L.U., National Taiwan University, Samsung Medical Center, Sungkyunkwan University, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Liaoning Cancer Hospital & Institute, China Medical University, Peking University Cancer Hospital, Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany), Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4318302245